A recent study demonstrated that activation of autologous T cells with an E3-ligase inhibitor also reverted PD-L1 mediated suppression of cytotoxic T cells, causing anti-tumor effects in a CLL xenograft model70. This evidence concerns the gene CD274 and B-cell chronic lymphocytic leukemia.